Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further dr...
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on, or objections to the issuance of the proposed registration on or before August 14, 2026. Such persons may also file a written request for a hearing on the application on or before August 14, 2026.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to
https://www.regulations.gov
and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on
https://www.regulations.gov.
If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on May 14, 2026, Veranova, L.P., 2003 Nolte Drive, West Deptford New Jersey 08066-1727, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled Substance
Gamma Hydroxybutyric Acid
Marihuana
Tetrahydrocannabinols
3,4-Methylenedioxymethamphetamine
Psilocybin
Dihydromorphine
Difenoxin
Fentanyl-Related Substance
Amphetamine
Methamphetamine
Lisdexamfetamine
Methylphenidate
Nabilone
4-Anilino-N-phenethyl-4-piperidine (ANPP)
Norfentanyl
Cocaine
Codeine
Dihydrocodeine
Oxycodone
Hydromorphone
Diphenoxylate
Ecgonine
Hydrocodone
Levorphanol
Meperidine
Methadone
Methadone intermediate
Morphine
Thebaine
Opium tincture
Oxymorphone
Noroxymorphone
Alfentanil
Remifentanil
Sufentanil
Tapentadol
Fentanyl
The company plans to bulk manufacture the listed controlled substances for use as internal intermediates and for sale to its customers. No other activities for these drug codes are authorized for this registration.